InvestSMART

Clarity Pharmaceuticals Ltd (ASX: CU6) - Announcements

Current share price for CU6 : $2.060 0.03 (1.48%)+

ASX company news and announcements for Clarity Pharmaceuticals Ltd (CU6) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Clarity Pharmaceuticals Ltd (CU6) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Clarity Pharmaceuticals Ltd (CU6), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Clarity Pharmaceuticals Ltd (CU6)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$772 Application for quotation of securities - CU6 17 May 2024 1:28PM $4.000 $2.070 fallen by 48.25%
$772 Cleansing Notice 3 May 2024 10:13AM $3.340 $2.070 fallen by 38.02%
$772 Application for quotation of securities - CU6 3 May 2024 10:09AM $3.310 $2.070 fallen by 37.46%
$772 Clarity to Present at 3 World Leading Conferences 3 May 2024 9:51AM $3.270 $2.070 fallen by 36.70%
$772 Change of Director's Interest Notice - Thomas 30 Apr 2024 4:04PM $2.800 $2.070 fallen by 26.07%
$772 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 3:37PM $2.790 $2.070 fallen by 25.81%
$772 Complete response with Cu-67 SAR-bisPSMA 30 Apr 2024 9:37AM $2.560 $2.070 fallen by 19.14%
$772 Application for quotation of securities - CU6 29 Apr 2024 9:52AM $2.530 $2.070 fallen by 18.18%
$772 Successful Completion of Retail Entitlement Offer 24 Apr 2024 9:48AM $2.520 $2.070 fallen by 17.86%
$772 Change in substantial holding 15 Apr 2024 5:01PM $2.650 $2.070 fallen by 21.89%
$772 Cleaning Notice 15 Apr 2024 10:02AM $2.680 $2.070 fallen by 22.76%
$772 Application for quotation of securities - CU6 15 Apr 2024 9:58AM $2.700 $2.070 fallen by 23.33%
$772 Ceasing to be a substantial holder - Taylor 15 Apr 2024 9:26AM $2.700 $2.070 fallen by 23.33%
$772 Change in substantial holding - Cabbit Pty Ltd 15 Apr 2024 9:23AM $2.700 $2.070 fallen by 23.33%
$772 Cleansing Notice 8 Apr 2024 9:15AM $2.640 $2.070 fallen by 21.59%
$772 Application for quotation of securities - CU6 5 Apr 2024 9:47AM $2.690 $2.070 fallen by 23.05%
$772 Clarity enters into Clinical Supply Agreement 4 Apr 2024 9:47AM $2.740 $2.070 fallen by 24.45%
$772 Despatch of Retail Entitlement Offer Booklet 4 Apr 2024 9:09AM $2.740 $2.070 fallen by 24.45%
$772 Completion of Placement and Institutional Entitlement Offer 28 Mar 2024 10:04AM $2.850 $2.070 fallen by 27.37%
$772 Cleansing Notice 26 Mar 2024 10:29AM $2.850 $2.070 fallen by 27.37%
$772 Proposed issue of securities - CU6 26 Mar 2024 10:29AM $2.850 $2.070 fallen by 27.37%
$772 Investor Presentation 26 Mar 2024 10:29AM $2.850 $2.070 fallen by 27.37%
$772 Clarity launches $121 million equity raise 26 Mar 2024 10:23AM $2.850 $2.070 fallen by 27.37%
$772 Trading Halt 25 Mar 2024 9:51AM $2.850 $2.070 fallen by 27.37%
$772 First participant treated in the last dose escalation cohort 22 Mar 2024 9:29AM $2.950 $2.070 fallen by 29.83%

251 - 275 of 514 results

Page 11 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.